Similar articles

• Does radioiodine treatment change the methylene diphosphonate uptake in a toxic thyroid nodule on bone scintigraphy?

  Mulazimoglu M, Karyagar S, Saglampinar S, Ozpacaci T. Mulazimoglu M, et al. Clin Nucl Med. 2008 Oct;33(10):731-3. doi: 10.1097/RLU.0b013e318184befb. Clin Nucl Med. 2008. PMID: 18806586 No abstract available.
• Incrustation and uptake of skeletal imaging agent in transitional cell carcinoma.

  Taniguchi M, Tatsuta N, Yokota H, Ouguchi M, Higashi K, Okimura T, Yamamoto I. Taniguchi M, et al. J Nucl Med. 1997 Aug;38(8):1206-7. J Nucl Med. 1997. PMID: 9255150
• [A new bone scanning agent: clinical experience of 99mTc-hydroxymethane diphosphonate (HMDP) (author's transl)].

  Fukunaga M, Fujita T, Shigeno C, Morita R, Torizuka K. Fukunaga M, et al. Kaku Igaku. 1981 Jul;18(6):863-7. Kaku Igaku. 1981. PMID: 7311135 Japanese. No abstract available.
• Diffuse and intense Tc-99m HMDP localization in the liver due to hypoxia secondary to respiratory failure.

  Shih WJ, Coupal J. Shih WJ, et al. Clin Nucl Med. 1994 Feb;19(2):116-20. doi: 10.1097/00003072-199402000-00008. Clin Nucl Med. 1994. PMID: 8187395 Review.
• Neonatal adrenal haemorrhage at bone scintigraphy: a case report.

  Jacobsson H, Kaiser S, Granholm T, Ringertz HG. Jacobsson H, et al. Pediatr Radiol. 1998 Nov;28(11):896-8. doi: 10.1007/s002470050492. Pediatr Radiol. 1998. PMID: 9799328 Review.